Contact HealthDay
Tel: 203.855.1400 or E-mail

News By Specialty

Allergy
Anesthesiology
Cardiology
Cosmetic Surgery
Critical Care
Dermatology
Diabetes & Endocrinology
Emergency Medicine
Family Practice
Gastroenterology
Geriatrics
Hematology & Oncology
HIV & AIDS
Infectious Disease
Internal Medicine
Nephrology
Neurology
Nursing
OBGYN & Women's Health
Ophthalmology
Orthopedics
Otolaryngology
Pain Management
Pathology
Pediatrics
Pharmacy
Psychiatry
Pulmonology
Radiology
Rheumatology
Surgery
Urology

Follow us on:

    


e-Healthcare Leadership Awards


FDA: Zofran 32-mg Dose Pulled From Market
The anti-nausea drug may cause serious heart problems at that dosage
This article is older than one year and is no longer available.

Copyright © 2012 HealthDay. All rights reserved.

April 23, 2014

Archive Search

By Keyword:
By Category:
By Topic:

Related Articles

FDA Approves Cyramza for Gastric Cancer

Lorazepam No Better Than Diazepam for Epilepsy in Kids

Pre-HPV Vaccine, Most Oropharyngeal Cancers HPV+ CME

Cancer Patients Need Anxiety, Depression Screening

Considerable Sudden Death in Hypertrophic Cardiomyopathy CME

Some Docs Still Prescribe Codeine for Peds Cough/URI CME